Daily Dose - Feb 24th, 2025
Daily Dose |
View online
February 24, 2025
Global CDMO Recipharm grows from product manufacturer to solution provider
CEO Greg Behar, who took Recipharm’s helm last year, has made targeted investments and divested its non-core sites to become a “more agile” company.
Read More
Celltrion updates strategy for potential Trump reciprocal tariffs on pharmaceuticals
The South Korean manufacturer and exporter of biosimilars said it has transferred about nine months’ worth of inventory for its products scheduled for U.S. sale in 2025.
Read More
Tiziana partners with CDMO Renaissance Lakewood to develop lead intranasal candidate
Renaissance will provide expertise in nasal drug manufacturing and regulatory compliance to help advance clinical development of Tiziana’s foralumab.
Read More